Edition:
United Kingdom

Catalyst Pharma Announces Proposed Public Offering Of Common Stock


Monday, 27 Nov 2017 

Nov 27 (Reuters) - Catalyst Pharmaceuticals Inc ::CATALYST PHARMACEUTICALS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING 11.0 MILLION COMMON SHARES.CATALYST-PLANS TO USE PROCEEDS TO FUND CLINICAL STUDIES OF FIRDAPSE FOR TREATMENT OF MUSK-ANTIBODY POSITIVE MYASTHENIA GRAVIS,SPINAL MUSCULAR ATROPHY​.- PLANS TO USE NET PROCEEDS FROM OFFERING TO FUND PRE-COMMERCIALIZATION ACTIVITIES FOR FIRDAPSE​.